FindTrial
Sign In

The Effect of Adding Dexmedetomidine to Ropivacaine for Fascia Iliaca Compartment Block (FICB) under Ultrasound-guided for Postoperative Pain Management After total hip replacement (THR)

The Effect of Adding Dexmedetomidine to Ropivacaine for Fascia Iliaca Compartment Block (FICB) under Ultrasound-guided for Postoperative Pain Management After total hip replacement (THR)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15006788
Enrollment
Unknown
Registered
2015-07-15
Start date
2015-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative analgesia

Interventions

Group 1:fascia iliaca compartment block with 0.5% ropivacaine
Group 2:fascia iliaca compartment block with 0.5% ropivacaine+ 0.5ug/kg dexmedetomidine
Group 3:fascia iliaca compartment block with 0.5% ropivacaine+ 1ug/kg dexmedetomidine
Group 4:Use morphine in the epidural space for postoperative analgesia

Sponsors

The 2nd Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Adults who have hip replacement surgery

Exclusion criteria

Exclusion criteria: Age=40 kg/m2; weight<50kg; coagulopathy; a history of relevant drug allergy; chronic hepatic or renal insufficiency; precnancy or breastfeeding; a history of alcohol or analgesics dependence; chronic pain.

Design outcomes

Primary

MeasureTime frame
the time for FICB;first time of pain;Median VAS pain scores while coughing and at rest;tramadol requirements;nausea and vomiting during the first 48 postoperative hours;urinary retention;satisfaction of the patients;RASS scores;—

Countries

China

Contacts

Public ContactWengang Ding
dingwg999@163.com+86 13936563265

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026